| Analysis | Metabolite Name | Measured Value | Units | Sample source | Age | Genotype | Treatment |
|---|---|---|---|---|---|---|---|
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.075350701 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.078356713 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.080360721 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.092225462 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.094655005 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.111758989 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.11827957 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.120234604 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.134897361 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.145682586 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | I/R |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.147612156 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | I/R |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.156295224 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | I/R |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.164646465 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.16519174 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.167676768 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.177974435 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.178286853 | lipid content in the sample (nmol/g) | Heart | young | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.180808081 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.181907571 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.194472876 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.204795205 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.207792208 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.213920164 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.217131474 | lipid content in the sample (nmol/g) | Heart | young | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.223776224 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.229083665 | lipid content in the sample (nmol/g) | Heart | young | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.251791198 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.290160643 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.294232649 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.299591002 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.301355579 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.301635992 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.302052786 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.306501548 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.311783107 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.312859885 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.314257028 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.317658349 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.326175869 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.327182045 | lipid content in the sample (nmol/g) | Heart | young | WT | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.327309237 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.329205366 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.336429309 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.336809176 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.345137157 | lipid content in the sample (nmol/g) | Heart | young | WT | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.354126679 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.3680798 | lipid content in the sample (nmol/g) | Heart | young | WT | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PG(18:2_22:6) | 0.375366569 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R+MIF20 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|